A novel risk stratification system for ischemic stroke in Japanese patients with non-valvular atrial fibrillation
K Okumura, H Tomita, M Nakai, E Kodani… - Circulation …, 2021 - jstage.jst.go.jp
Background: Recently, identification of independent risk factors for ischemic stroke in
Japanese non-valvular atrial fibrillation (NVAF) patients was made by analyzing the 5 major …
Japanese non-valvular atrial fibrillation (NVAF) patients was made by analyzing the 5 major …
Meta-analysis of CHADS2 score in predicting atrial fibrillation
Y Yang, Z Zhang, CY Ng, G Li, T Liu - The American journal of cardiology, 2015 - Elsevier
The CHADS 2 score is a validated clinical tool used for the risk stratification of stroke in the
presence of atrial fibrillation (AF). Recently, some studies have shown that CHADS 2 score …
presence of atrial fibrillation (AF). Recently, some studies have shown that CHADS 2 score …
Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?
The current atrial fibrillation (AF) management guidelines wisely indicate that oral
anticoagulant (OAC) therapy 'should be considered'(Class IIa) in patients with CHA2DS2 …
anticoagulant (OAC) therapy 'should be considered'(Class IIa) in patients with CHA2DS2 …
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
Z Hijazi, J Lindbäck, JH Alexander… - European heart …, 2016 - academic.oup.com
Aims Atrial fibrillation (AF) is associated with an increased risk of stroke, which is currently
estimated by clinical characteristics. The cardiac biomarkers N-terminal fragment B-type …
estimated by clinical characteristics. The cardiac biomarkers N-terminal fragment B-type …
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
GYH Lip - European heart journal, 2013 - academic.oup.com
Decision making with regard to thromboprophylaxis should be based upon the absolute
risks of stroke/thromboembolism and bleeding and the net clinical benefit for a given patient …
risks of stroke/thromboembolism and bleeding and the net clinical benefit for a given patient …
Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score
R Kabra, S Girotra, M Vaughan Sarrazin - Journal of the American College …, 2016 - jacc.org
Background: Prior studies show that African-American patients have a higher risk of stroke
compared with Caucasians. Objectives: This study hypothesized addition of African …
compared with Caucasians. Objectives: This study hypothesized addition of African …
CHA2DS2-VASc score and prognosis in ischemic strokes with atrial fibrillation
E Giralt-Steinhauer, E Cuadrado-Godia, Á Ois… - Journal of …, 2012 - Springer
Abstract The CHA 2 DS 2-VASc score was developed to improve stroke risk stratification in
atrial fibrillation (AF) patients. We sought to analyze the distribution and prognostic value of …
atrial fibrillation (AF) patients. We sought to analyze the distribution and prognostic value of …
Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review
ED Borre, A Goode, G Raitz, B Shah… - Thrombosis and …, 2018 - thieme-connect.com
Background Atrial fibrillation (AF) is a common cardiac arrhythmia that increases the risk of
stroke. Medical therapy for decreasing stroke risk involves anticoagulation, which may …
stroke. Medical therapy for decreasing stroke risk involves anticoagulation, which may …
Atrial fibrillation burden: an update—the need for a CHA2DS2-VASc-AFBurden score
KD Tiver, J Quah, A Lahiri, AN Ganesan… - EP …, 2021 - academic.oup.com
Atrial fibrillation (AF) is an established independent risk factor for stroke. Current guidelines
regard AF as binary; either present or absent, with the decision for anti-coagulation driven by …
regard AF as binary; either present or absent, with the decision for anti-coagulation driven by …
[HTML][HTML] A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice
Background: Anticoagulation management of patients with atrial fibrillation (AF) should be
tailored individually on the basis of ischemic stroke risk. The objective of this study was to …
tailored individually on the basis of ischemic stroke risk. The objective of this study was to …